Bartosz Bartczak

Physiotherapist with 20 years of clinical experience | Founder of One Peptides

For 20 years he has explored the topic of health, movement, and human optimization. As a graduate of Poznan University of Medical Sciences, he combines academic foundations with modern physiotherapy methods. His goal is restoring full function and quality of life to people struggling with pain, mobility limitations, and the aftermath of injuries.

Role in One Peptides

Bartosz Bartczak is the founder of One Peptides and lead author of content written from a clinical perspective. Over two decades of work with sports and orthopedic patients built unique grounding: real understanding of how the body regenerates after injury, what limits age and training impose, and how recovery peptides can support these processes in clinical protocols.

He works with MPharm Aneta Kropicka, pharmaceutical reviewer. Dual-voice E-E-A-T standard — Bartosz brings clinical perspective, Aneta brings pharmaceutical perspective. Together they set the quality standard for every article on one-peptides.com.

Professional background

Bartosz graduated from Poznan University of Medical Sciences and has been practicing clinical physiotherapy for over 20 years. Specializations cover musculoskeletal injuries, recovery from sports trauma, chronic pain therapy, and functional restoration in patients after orthopedic procedures.

Clinical experience gave Bartosz grounding impossible to gain from literature alone: real understanding of soft tissue regeneration timescales. Tendons do not heal in a week. Muscles do not return to full strength in three days. BPC-157 and TB-500 are not shortcuts — they are one element of a program that requires months of systematic work.

What he creates at One Peptides

Recovery peptides — BPC-157, TB-500, regenerative combinations (BPC vs TB-500 comparison).
GLP-1 peptides in metabolic context — full guide to GLP-1 peptides.
Peptides in cosmetology and skin regeneration — GHK-Cu in healing and connective tissue rebuilding protocols.
Longevity peptides — Epithalon and the telomere-modulation hypothesis.
Regulatory status and safety — every peptide has its legal framework: RUO, dietary supplement, or drug.
Research peptide quality — HPLC standards and certificates. In his clinical protocols, no peptide appears without a COA.

Philosophy

Clinic over theory. Twenty years with patients teaches one thing: between a good in vitro mechanism and a real clinical effect lies a long, winding road.

Recovery is a process, not a shortcut. Peptides are one of the tools in a program supporting regeneration — alongside diet, sleep, progressive training, manual physiotherapy, and nervous system hygiene.

Safety as priority. Every research peptide has its limits — interactions, contraindications, regulatory frames, and WADA status. Collaboration with Aneta Kropicka as pharmaceutical reviewer further strengthens this standard.

Clinical specializations

Recovery from musculoskeletal injuries — muscle tears, tendinopathies, post-orthopedic rehabilitation
Chronic pain therapy — supporting regeneration in patients after long-term overload
Athlete optimization — recovery support in training protocols, including the SARM context and WADA profiles
Functional geriatrics — maintaining function in 50+ patients, including the longevity-peptide context

Education and credentials

Certified physiotherapist — Poznan University of Medical Sciences
20+ years of clinical physiotherapy experience (2006–2026)
Founder of One Peptides — a project combining access to research peptides with reliable clinical education

Cross-reference: See also Bartosz’s Polish-language bio at one-peptides.pl/o-zespole-bartoszbartczak/.